Found 86 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2020
J. B. Goll, Li, S., Edwards, J. L., Bosinger, S. E., Jensen, T. L., Wang, Y., Hooper, W. F., Gelber, C. E., Sanders, K. L., Anderson, E. J., Rouphael, N., Natrajan, M. S., Johnson, R. A., Sanz, P., Hoft, D., and Mulligan, M. J., “Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
2019
J. Bolaños-Meade, Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., Bin Chen, Y. -, Damon, L. E., Efebera, Y. A., Geller, N. L., Giralt, S. A., Hari, P., Holtan, S. G., Horowitz, M. M., Jacobsohn, D. A., Jones, R. J., Liesveld, J. L., Logan, B. R., MacMillan, M. L., Mielcarek, M., Noel, P., Pidala, J., Porter, D. L., Pusic, I., Sobecks, R., Solomon, S. R., Weisdorf, D. J., Wu, J., Pasquini, M. C., and Koreth, J., “Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with”, Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
K. M. Keppler-Noreuil, Lozier, J., Oden, N., Taneja, A., Burton-Akright, J., Sapp, J. C., and Biesecker, L. G., “Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.”, Am J Med Genet C Semin Med Genet, vol. 181, no. 4, pp. 571-581, 2019.
C. S Johnston, Elm, J. J., J Easton, D., Farrant, M., Barsan, W. G., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zurita, K. G., Albers, G. W., Cucchiara, B. L., Kleindorfer, D. O., Lutsep, H. L., Pearson, C., Sethi, P., and Vora, N., “Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.”, Circulation, vol. 140, no. 8, pp. 658-664, 2019.
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., “Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.”, Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
2018
C. J. Nobles, Schisterman, E. F., Ha, S., Louis, G. M. Buck, Sherman, S., and Mendola, P., “Time-varying cycle average and daily variation in ambient air pollution and fecundability.”, Hum Reprod, vol. 33, no. 1, pp. 166-176, 2018.
E. Shemesh, Duncan, S., Anand, R., Shneider, B. L., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Annunziato, R. A., and Bucuvalas, J. C., “Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort.”, Liver Transpl, vol. 24, no. 1, pp. 80-88, 2018.
G. Gensler, Clemons, T. E., Domalpally, A., Danis, R. P., Blodi, B., Wells, J., Rauser, M., Hoskins, J., G Hubbard, B., Elman, M. J., Fish, G. E., Brucker, A., Margherio, A., and Chew, E. Y., “Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”, Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
K. A. Holtz, Szefer, E., Noonan, V. K., Kwon, B. K., and Mills, P. B., “Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study.”, Spinal Cord, vol. 56, no. 12, pp. 1176-1183, 2018.
2017
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B., “Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.”, Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.
2016
R. Kosoy, Agashe, C., Grishin, A., Leung, D. Y., Wood, R. A., Sicherer, S. H., Jones, S. M., A Burks, W., Davidson, W. F., Lindblad, R. W., Dawson, P., Merad, M., Kidd, B. A., Dudley, J. T., Sampson, H. A., and M Berin, C., “Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype.”, PLoS One, vol. 11, no. 10, p. e0163831, 2016.
S. Shenoy, Eapen, M., Panepinto, J. A., Logan, B. R., Wu, J., Abraham, A., Brochstein, J., Chaudhury, S., Godder, K., Haight, A. E., Kasow, K. A., Leung, K., Andreansky, M., Bhatia, M., Dalal, J., Haines, H., Jaroscak, J., Lazarus, H. M., Levine, J. E., Krishnamurti, L., Margolis, D., Megason, G. C., Yu, L. C., Pulsipher, M. A., Gersten, I., DiFronzo, N., Horowitz, M. M., Walters, M. C., and Kamani, N., “A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.”, Blood, vol. 128, no. 21, pp. 2561-2567, 2016.
2014
E. V. Maarseveen, Rogers, C., Trofe-Clark, J., Lghoul, F., Wong, M., Zuilen, A. V., Mudrikova, T., Barin, B., Stock, P., and Frassetto, L., “Tacrolimus Exposure and its Relation with Clinical Outcomes in HIV Infected Kidney Transplant Recipients on Antiretroviral Agents: An Area-Under-The-Curve Driven Analysis”, in World Transplant Congress, San Francisco, CA, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. - H., Carter, S. L., Horowitz, M. M., and Antin, J. H., “Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.”, Blood, vol. 124, no. 8, pp. 1372-7, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT”, Blood, vol. 124, pp. 1372-1377, 2014.
N. Oden and Sharma, G., “Tangency Outcomes for Clinical Trials”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Davis, M. D., and Ferris, F. L., “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Davis, M. D., 3rd, F. L. Ferris, and AREDS), T. Age- Relate, “Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36”, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
G. Sharma, Van Veldhuisen, P., and Allen, C. A., “Tracking and Monitoring Trial Progress in NIDA CTN Studies”, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., “Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial”, JAMA, vol. 311, pp. 62-73, 2014.
E. Atallah, Bylow, K., Troy, J., and W, S., “Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)”, Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., “Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).”, Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
2013
E. Koo, Chang, J. R., Agrón, E., Clemons, T. E., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 71-81, 2013.
E. Koo, Chang, J., E, A., Clemons, T. E., Sperduto, R. D., 3rd, F. L. Ferris, Chew, E. Y., and AREDS), T. Age- Relate, “Ten-year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 33”, Ophthalmic Epidemiology, vol. 20, pp. 71-81, 2013.